Company Snapshot

Investment Thesis

Thermo Fisher Scientific is a diversified life sciences company providing analytical instruments, specialty diagnostics, bioproduction supplies, and contract research services to pharma, biotech, and academia.

  • Scale & Breadth: Thermo Fisher combines category-leading instruments with consumables and services, capturing end-to-end workflows for scientists.
  • Bioproduction Strength: Single-use technologies, cell culture media, and analytics support biologics and cell therapy manufacturing growth.
  • Services Expansion: PPD clinical research and pharma services provide recurring revenue and deeper customer entanglement.

Operating Highlights

Recurring Revenue Consumables and services represent more than half of total revenue
Customer Base Hundreds of thousands of customers across pharma, biotech, healthcare, and academia
Innovation Engine Invests ~$1.5B annually in R&D to advance instruments and digital workflows
Global Footprint Manufacturing, distribution, and service operations in 50+ countries

Figures drawn from Thermo Fisher 2024 investor materials.

Recent Performance

MTD +0.11%
QTD +7.02%
YTD +8.69%
5Y +11.16%

Thermo Fisher shares have rebounded as biopharma funding stabilizes and China headwinds ease, supporting mid-single-digit core growth guidance.

Strategic Insights

Biopharma Tailwinds

Pipeline complexity and biologics growth drive demand for Thermo Fisher's production and analytical solutions.

Diagnostics Expansion

Molecular diagnostics, clinical chemistry, and specialty testing extend Thermo Fisher into hospital labs.

Digital Lab Transformation

Connected instruments and informatics streamline workflows, enabling higher productivity for scientists.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...